Monocyte Activation in Preclinical Atherosclerosis

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Atherosclerosis
Interventions
OTHER

In vitro estimation of individual reactivity of monocytes

Technique for isolation/separation of monocytes with culture purity more than 95 % CD14-positive cells according to flow cytometry, the share of viable cells at least 98% by trypan blue vital staining, capable of producing TNFa at concentration of at least 50 pg/ml when stimulated with 100 ng/ml IFN-gamma, and CCL18 at concentration at least 30 pg/ml when stimulated with 10 ng/ml interleukin.

Trial Locations (1)

121609

Institute for Atherosclerosis Research, Moscow

All Listed Sponsors
lead

Institute for Atherosclerosis Research, Russia

OTHER

NCT02126280 - Monocyte Activation in Preclinical Atherosclerosis | Biotech Hunter | Biotech Hunter